What is the market doing?
What the tape says about SMMT
Summit Therapeutics Inc. is −34% over the past year while the S&P 500 is +20%: 55 points behind the market. Through the fall, its own insiders bought $104M more stock than they sold.
−34%
1-year return · S&P 500 +20%
- vs 200-day average
- +3.8%
vs 200-day average · close to trend
- RSI (14)
- 76
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-09-08
- $17.27
- 1 monthS&P 500 −0.30%
- +28%
- 1 yearS&P 500 +20%
- −34%
- 5 yearsS&P 500 +85%
- +122%
- vs 50-day average$14.11
- +22%
- 52-week high
- $26.98
- 52-week low
- $12.42
- Annualised volatility
- 99%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $104M
| Year | Return |
|---|---|
| 2026 (year to date) | −1.3% |
| 2025 | −2.0% |
| 2024 | +584% |
| 2023 | −39% |
| 2022 | +58% |
| 2021 | −43% |
| 2020 | +194% |
| 2019 | +39% |
| 2018 | −90% |
| 2017 | +29% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +12% |
| Feb | 10 | 5 of 10 | +6.4% |
| Mar | 10 | 4 of 10 | +4.2% |
| Apr | 10 | 5 of 10 | +2.1% |
| May | 10 | 6 of 10 | +11% |
| Jun | 10 | 3 of 10 | −11% |
| Jul | 11 | 6 of 11 | +5.7% |
| Aug | 11 | 6 of 11 | +0.81% |
| Sep | 11 | 5 of 11 | +11% |
| Oct | 10 | 3 of 10 | −5.0% |
| Nov | 10 | 3 of 10 | −2.1% |
| Dec | 10 | 4 of 10 | +38% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.